Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma

Leukemia and Lymphoma

Volumn 46, Issue 11, 2005, Pages 1553-1559

  Yamada, Yasuaki ^a   Kamihira, S ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

ATLL; HTVL; P14Arf; p16Ink4a; p53

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 16P; CHROMOSOME ABERRATION; GENE MUTATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; LEUKEMIA CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

DISEASE PROGRESSION; GENE SILENCING; GENES, CDC; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED;

EID: 28244499237     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500244217     Document Type: Article

References (47)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-492.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
3. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984;81:2534-2537.
4. Kinoshita K, Amagasaki T, Ikeda S, Suzuyama J, Toriya K, Nishino K, et al. Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus. Blood 1985;66:120-127.
5. Shimoyama M, members of The Lymphoma Study Group (1984-1987). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the lymphoma study group (1984-1987). Br J Haematol 1991;79:428-437.
6. Kinoshita K, Hino S, Amagasaki T, Ikeda S, Yamada Y, Suzuyama J, et al. Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Gann (Jpn J Cancer Res) 1984;75:103-105.
7. Kinoshita K, Amagasaki T, Hino S, Doi H, Yamanouchi K, Ban N, et al. Milk-borne transmission of HTLV-1 from carrier mothers to their children. Jpn J Cancer Res 1987;76: 1147-1153.
8. Jeang KT. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κB. Cytokine Growth Factor Rev 2001;12:207-217.
9. Yoshida M. Molecular biology of HTLV-1: pleiotropic function of Tax protein in cell regulation. In: Sugamura K, Uchiyama T, Matsuoka M, Kannagi M, editors. Gann monograph on cancer research No.50, two decades of adult T-cell leukemia and HTLV-1 research. Tokyo: Japan Scientific Societies Press; 2003. pp 11-18.
10. Ohtani K, Nakamura M. Molecular mechanisms of Tax-mediated cell growth of human T lymphocytes. In: Sugamura K, Uchiyama T, Matsuoka M, Kannagi M, editors. Gann monograph on cancer research No.50, two decades of adult T-cell leukemia and HTLV-1 research. Tokyo: Japan Scientific Societies Press; 2003. pp 43-60.
11. Azran I, Schavinsky-Khrapunsky Y, Aboud M. Role of Tax protein in human T-cell leukemia virus type-1 leukemogenicity. Retrovirology 2004;1:20.
12. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13: 1501-1512.
13. Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001;1:222-231.
14. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-799.
15. Hollstein M, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
16. Sheer CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002;2:103-112.
17. El-Deiry WS. Regulation of p53 downstream genes. Semin Cancer Biol 1998;8:345-357.
18. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 2003;15:164-171.
19. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumor supperssor with p53. Proc Natl Acad Sci USA 1998;95:8292-8297.
20. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005;433:278-285.
21. Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000;77:81-137.
22. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res 1994;54: 4855-4878.
23. Guimaraes DP, Hainaut P. TP53: a key gene in human cancer. Biochimie 2002;84:83-93.
24. Nagai H, Kinoshita T, Imamura J, Murakami Y, Hayashi K, Mukai K, et al. Genetic alteration of p53 in some patients with adult T-cell leukemia. Jpn J Cancer Res 1991;82:1421-1427.
25. Sugito S, Yamato K, Sameshima Y, Yokota J, Yano S, Miyoshi I. Adult T-cell leukemia: structures and expression of the p53 gene. Int J Cancer 1991;49:880-885.
26. Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K, Koeffler HP. Mutations of the p53 gene in adult T-cell leukemia. Blood 1992;79:477-480.
27. Nishimura S, Asou N, Suzushima H, Okubo T, Fujimoto T, Osato M, et al. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia. Leukemia 1995;9:598-604
28. Tawara M, Hogerzeil SJ, Yamada Y, Takasaki Y, Soda H, Hasegawa H, et al. Impact of p53 aberration on the progression of adult T-cell leukemia/lymphoma. Cancer Lett 2005; in press.
29. Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994;54: 6321-6324.
30. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-756.
31. Kamb, A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-440.
32. Ogawa S, Hangaishi A, Miyawaki S, Hirosawa S, Miura Y, Takeyama K, et al. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood 1995;86:1548-1556.
33. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 1995;85:2699-2704.
34. Yamada Y, Hatta Y, Murata K, Sugahara K, Ikeda S, Mine M, et al. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 1997;15:1778-1785.
35. Takasaki Y, Yamada Y, Sugahara K, Hayashi T, Dateki N, Harasawa H, et al. Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation. Br J Haematol 2003;122:253-259.
36. Hofmann WK, Tsukasaki K, Takeuchi N, Takeuchi S, Koeffler HP. Methylation analysis of cell cycle control genes in adult T-cell leukemia/lymphoma. Leuk Lymphoma 2001;42:1107-1109.
37. Trovato R, Cereseto A, Takemoto S, Gessain A, Watanabe T, Waldmann T, Franchini G. Deletion of the p16INK4A gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16INK4A promoter in HTLV type 1-infected T cell lines. AIDS Res Hum Retroviruses 2000;16: 709-713.
38. Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res 2000;60:1043-1048.
39. INK4C in adult T-cell leukemia (ATL) and non-Hodgkin's lymphoma. Br J Haematol 1997;99:665-667.
40. Shiohara M, Spirin K, Said JW, Gombart AF, Nakamaki T, Takeuchi S, et al. Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies. Leukemia 1996;10:1897-1900.
41. Shiohara M, Koike K, Komiyama A, Koeffler HP. p21WAF1 mutations and human malignancies. Leuk Lymphoma 1997; 26:35-41.
42. Hatta Y, Koeffler HP. Role tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). Leukemia 2002;16:1069-1085.
43. KP1 gene in non-Hodgkin's lymphoma and adult T-cell leukemia/lymphoma. Blood 1995; 86:1924-1930.
44. Hatta Y, Yamada Y, Tomonaga M, Koeffler HP. Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL). Leukemia 1997;11:984-989.
45. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83:993-1000.
46. Arf. Proc Natl Acad Sci USA 1997;94:669-673.
47. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997;91:649-659.